Sleep is supposed to be restful, so it’s extra frustrating when back, hip and leg pain stop you from really relaxing. Luckily ...

Eli Lilly's experimental drug, retatrutide, showed strong results in a late-stage trial, helping patients lose nearly 29% of ...

Retatrutide, Eli Lilly’s triple-hormone obesity drug, delivers up to 28.7% weight loss and major knee pain relief in ...

The maker of Zepbound reported results from a study of retatrutide, which targets three hormones in the body and led to much more weight loss than any approved drug.

Here’s what to know about how common bottom-of-foot pain is, why it happens and the most reliable ways to find relief.

Jakob Roze, CSCS, is a health writer and high-end personal trainer. He is the founder and CEO of RozeFit, a high-end concierge personal training practice and online blog. Exercise can be a safe and ...

Professional organizations such as the American College of Rheumatology and the American Academy of Orthopaedic Surgeons strongly recommend exercise and other conservative modalities of care prior to ...

A novel triple receptor agonist conferred weight loss of up to 28.7% at 68 weeks and reductions in pain for adults with ...

Topline phase 3 results show retatrutide led to meaningful weight reduction and pain relief in adults with overweight or obesity and knee OA.

Knee pain often results from injuries to muscles, tendons, or ligaments. Deep vein thrombosis is a severe condition that can cause pain behind your knee. Most minor knee injuries can heal on their own ...

If acute pain is interfering with your daily activities, prescription topical patches can bring relief right where you need ...

In addition, the obesity drug also improved knee pain in participants, Eli Lilly noted. ・Seven additional Phase 3 trials for ...